{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:13:20Z","timestamp":1788416000080,"version":"build-2803163510"},"reference-count":170,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Interleukin-1 receptor-associated kinase 1 (IRAK1) is a serine\/threonine kinase that functions as a central transducer of Toll-like receptor (TLR) and interleukin-1 receptor (IL-1R) signaling, linking pathogen recognition to the activation of nuclear factor kappa B (NF-\u03baB), mitogen-activated protein kinases (MAPK), and interferon regulatory factors (IRFs). Although the role of IRAK1 in innate immune signaling is well established, its regulatory complexity remains incompletely characterized, particularly regarding the dynamic phosphorylation landscape that governs activation, substrate specificity, and signal termination. This review presents a systematic phosphoproteomics map of IRAK1 phosphorylation, integrating 213 profiling and 33 differential mass spectrometry-based phosphoproteomic datasets from 56 studies. Eighteen phosphosites were identified in the profiling datasets and 16 in the differential datasets across independent expression and acquisition conditions. Among these, Ser131 (detected in 128 profiling and 26 differential datasets) and Ser110 (detected in 26 profiling and nine differential datasets) were the most frequently observed sites. Most high-frequency phosphosites are located within the serine\/threonine kinase domain and the C-terminal proline\/serine\/threonine-rich (ProST) regulatory region of the protein. However, frequent detection does not necessarily indicate functional significance, and these sites are potential candidates for targeted validation. In addition to canonical phosphorylation, this review evaluates the coordinated interplay among phosphorylation, K63\/K48-linked ubiquitination, and SUMOylation, which together determine whether signaling is propagated or terminated. We also discuss the non-canonical functions of IRAK1 in transcriptional regulation, antiviral defense, cytoskeletal organization, and oncogenic signaling, and evaluate current pharmacological inhibitors of IRAK1, including Pacritinib, JH-X-119-01, 1, 4-naphthoquinone, and rosoxacin. Overall, this review provides a systematic, data-informed framework for prioritizing phosphosite-specific functional studies to identify phospho-dependent interaction interfaces as potential targets for precision clinical interventions and biomarker development in inflammatory diseases and cancer.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1937314","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:21:52Z","timestamp":1788412912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Phosphoregulation of interleukin-1 receptor-associated kinase 1 in inflammatory signaling"],"prefix":"10.3389","volume":"17","author":[{"given":"Manasa","family":"Suresh","sequence":"first","affiliation":[{"name":"Centre for Integrative Omics Data Science, Yenepoya (Deemed to be University)","place":["Mangalore, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysilla Espy","family":"Vaz","sequence":"additional","affiliation":[{"name":"Centre for Integrative Omics Data Science, Yenepoya (Deemed to be University)","place":["Mangalore, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"Dcunha","sequence":"additional","affiliation":[{"name":"Centre for Integrative Omics Data Science, Yenepoya (Deemed to be University)","place":["Mangalore, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Raju","sequence":"additional","affiliation":[{"name":"Centre for Integrative Omics Data Science, Yenepoya (Deemed to be University)","place":["Mangalore, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha M.","family":"Pinto","sequence":"additional","affiliation":[{"name":"School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey","place":["Guildford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saptami","family":"Kanekar","sequence":"additional","affiliation":[{"name":"Centre for Integrative Omics Data Science, Yenepoya (Deemed to be University)","place":["Mangalore, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5252.1128","article-title":"Irak: a kinase associated with the interleukin-1 receptor","volume":"271","author":"Cao","year":"1996","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/s1097-2765(03)00053-4","article-title":"Functional diversity and regulation of different interleukin-1 receptor-associated kinase (Irak) family members","volume":"11","author":"Janssens","year":"2003","journal-title":"Mol Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.082100399","article-title":"Irak-4: a novel member of the Irak family with the properties of an Irak-kinase","volume":"99","author":"Li","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5343.1612","article-title":"Irak (Pelle) family member Irak-2 and Myd88 as proximal mediators of Il-1 signaling","volume":"278","author":"Muzio","year":"1997","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.27.19403","article-title":"Irak-M is a novel member of the Pelle\/interleukin-1 receptor-associated kinase (Irak) family","volume":"274","author":"Wesche","year":"1999","journal-title":"J Biol Chem"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1714386114","article-title":"Crystal structure of human Irak1","volume":"114","author":"Wang","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1133354","article-title":"Regulation of innate immune signaling by Irak proteins","volume":"14","author":"Pereira","year":"2023","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2020.11.004","article-title":"Dimeric structure of the pseudokinase Irak3 suggests an allosteric mechanism for negative regulation","volume":"29","author":"Lange","year":"2021","journal-title":"Structure"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(00)80402-1","article-title":"Myd88: an adapter that recruits Irak to the Il-1 receptor complex","volume":"7","author":"Wesche","year":"1997","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061523","article-title":"Essential role of Irak-4 protein and its kinase activity in toll-like receptor-mediated immune responses but not in Tcr signaling","volume":"204","author":"Kawagoe","year":"2007","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M309251200","article-title":"Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling","volume":"279","author":"Kollewe","year":"2004","journal-title":"J Biol Chem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.022392","article-title":"An oligomeric signaling platform formed by the toll-like receptor signal transducers Myd88 and Irak-4","volume":"284","author":"Motshwene","year":"2009","journal-title":"J Biol Chem"},{"key":"B13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2214\/ajr.157.1.2048534","article-title":"Intraperitoneal contrast material improves the Ct detection of peritoneal metastases","volume":"157","author":"Halvorsen","year":"1991","journal-title":"AJR Am J Roentgenol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/383443a0","article-title":"Traf6 is a signal transducer for interleukin-1","volume":"383","author":"Cao","year":"1996","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.34.21540","article-title":"The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation","volume":"272","author":"Yamin","year":"1997","journal-title":"J Biol Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20042372","article-title":"Interleukin-1 receptor-associated kinase-1 plays an essential role for toll-like receptor (Tlr)7- and Tlr9-mediated interferon-alpha induction","volume":"201","author":"Uematsu","year":"2005","journal-title":"J Exp Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M410369200","article-title":"Irak1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression","volume":"279","author":"Huang","year":"2004","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0900774106","article-title":"Identification of the phosphorylation sites on the E3 ubiquitin ligase Pellino that are critical for activation by Irak1 and Irak4","volume":"106","author":"Smith","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nature03547","article-title":"Spatiotemporal regulation of myd88-irf-7 signalling for robust type-I interferon induction","volume":"434","author":"Honda","year":"2005","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1267","article-title":"Phosphositeplus, 2014: mutations, ptms and recalibrations","volume":"43","author":"Hornbeck","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm902","article-title":"Networkin: a resource for exploring cellular phosphorylation networks","volume":"36","author":"Linding","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki471","article-title":"Kinasephos: a web tool for identifying protein kinase-specific phosphorylation sites","volume":"33","author":"Huang","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B23","volume-title":"Gene ID: 3654, IRAK1 (Interleukin 1 Receptor Associated Kinase 1) [Internet]","year":"2006"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-5793(00)01759-2","article-title":"Translocation of the interleukin-1 receptor-associated kinase-1 (Irak-1) into the nucleus","volume":"477","author":"Bol","year":"2000","journal-title":"FEBS Lett"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.513","article-title":"Irak signalling in cancer","volume":"112","author":"Rhyasen","year":"2015","journal-title":"Br J Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2006.03.021","article-title":"Differential regulation of interleukin-1 receptor associated kinase 1 (Irak1) splice variants","volume":"44","author":"Su","year":"2007","journal-title":"Mol Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2007.08.009","article-title":"Irak1: a critical signaling mediator of innate immunity","volume":"20","author":"Gottipati","year":"2008","journal-title":"Cell Signal"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205160200","article-title":"Identification of threonine 66 as a functionally critical residue of the interleukin-1 receptor-associated kinase","volume":"277","author":"Ross","year":"2002","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-5793(99)00322-1","article-title":"Effects of Il-1 receptor-associated kinase (Irak) expression on Il-1 signaling are independent of its kinase activity","volume":"448","author":"Knop","year":"1999","journal-title":"FEBS Lett"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1042\/bj3390227","article-title":"Overexpression of an enzymically inactive interleukin-1-receptor-associated kinase activates nuclear factor-kappab","volume":"339","author":"Maschera","year":"1999","journal-title":"Biochem J"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.11.068","article-title":"Regulation of Irak-4 kinase activity via autophosphorylation within its activation loop","volume":"352","author":"Cheng","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021790","article-title":"Inhibition of interleukin 1 receptor\/toll-like receptor signaling through the alternatively spliced, short form of Myd88 is due to its failure to recruit Irak-4","volume":"197","author":"Burns","year":"2003","journal-title":"J Exp Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.071054198","article-title":"Il-1-induced Nfkappa B and c-Jun N-terminal kinase (Jnk) activation diverge at Il-1 receptor-associated kinase (Irak)","volume":"98","author":"Li","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2174\/1568014053005345","article-title":"Iraks: key regulatory kinases of innate immunity","volume":"4","author":"Suzuki","year":"2005","journal-title":"Curr Med Chem - Anti-Inflammatory Anti-Allergy Agents"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nri2079","article-title":"The family of five: Tir-domain-containing adaptors in toll-like receptor signalling","volume":"7","author":"O'Neill","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nature09121","article-title":"Helical assembly in the Myd88-Irak4-Irak2 complex in Tlr\/Il-1r signalling","volume":"465","author":"Lin","year":"2010","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M102262200","article-title":"Irak-mediated translocation of Traf6 and Tab2 in the interleukin-1-induced activation of Nfkappa B","volume":"276","author":"Qian","year":"2001","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M609503200","article-title":"Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation","volume":"282","author":"Lamothe","year":"2007","journal-title":"J Biol Chem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/35085597","article-title":"Tak1 is a ubiquitin-dependent kinase of Mkk and Ikk","volume":"412","author":"Wang","year":"2001","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/ncb0805-758","article-title":"Ubiquitin signalling in the Nf-kappab pathway","volume":"7","author":"Chen","year":"2005","journal-title":"Nat Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of Nf-[kappa]B activity","volume":"18","author":"Karin","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor Nf-kappab pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0605298103","article-title":"Nf-kappab-dependent induction of microrna Mir-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.12.2073","article-title":"Interleukin (Il)-1 receptor-associated kinase (Irak) requirement for optimal induction of multiple Il-1 signaling pathways and Il-6 production","volume":"187","author":"Kanakaraj","year":"1998","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1126\/stke.2003.171.re3","article-title":"The interleukin-1 receptor\/toll-like receptor superfamily: signal transduction during inflammation and host defense","volume":"2003","author":"Dunne","year":"2003","journal-title":"Sci STKE"},{"key":"B50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-3-642-59430-4_3","article-title":"Signal transduction pathways activated by the Il-1 receptor\/toll-like receptor superfamily","volume":"270","author":"O'Neill","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adh3449","article-title":"A noncanonical Irak4-Irak1 pathway counters DNA damage-induced apoptosis independently of Tlr\/Il-1r signaling","volume":"16","author":"Li","year":"2023","journal-title":"Sci Signal"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2007.12.012","article-title":"The involvement of the interleukin-1 receptor-associated kinases (Iraks) in cellular signaling networks controlling inflammation","volume":"42","author":"Ringwood","year":"2008","journal-title":"Cytokine"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nature07924","article-title":"Zc3h12a is an Rnase essential for controlling immune responses by regulating Mrna decay","volume":"458","author":"Matsushita","year":"2009","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2137","article-title":"The Ikappab kinase complex regulates the stability of cytokine-encoding Mrna induced by Tlr-Il-1r by controlling degradation of Regnase-1","volume":"12","author":"Iwasaki","year":"2011","journal-title":"Nat Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.007719","article-title":"Viperin interacts with the kinase Irak1 and the E3 ubiquitin ligase Traf6, coupling innate immune signaling to antiviral ribonucleotide synthesis","volume":"294","author":"Dumbrepatil","year":"2019","journal-title":"J Biol Chem"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.1c01045","article-title":"The antiviral enzyme, Viperin, activates protein ubiquitination by the E3 ubiquitin ligase, Traf6","volume":"143","author":"Patel","year":"2021","journal-title":"J Am Chem Soc"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00553","article-title":"Il-1 receptor-associated kinase signaling and its role in inflammation, cancer progression, and therapy resistance","volume":"5","author":"Jain","year":"2014","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201700966R","article-title":"Regulation of Il-1 signaling through control of focal adhesion assembly","volume":"32","author":"Wang","year":"2018","journal-title":"FASEB J"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.059501","article-title":"Irak-1 contributes to lipopolysaccharide-induced reactive oxygen species generation in macrophages by inducing Nox-1 transcription and Rac1 activation and suppressing the expression of antioxidative enzymes","volume":"284","author":"Maitra","year":"2009","journal-title":"J Biol Chem"},{"key":"B60","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12964-022-00879-3","article-title":"The Rock-Ezrin signaling pathway mediates Lps-induced cytokine production in pulmonary alveolar epithelial cells","volume":"20","author":"Ding","year":"2022","journal-title":"Cell Commun Signal"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3390\/cells13201690","article-title":"Interleukin-1 receptor-associated kinase 1 in cancer metastasis and therapeutic resistance: Mechanistic insights and translational advances","volume":"13","author":"Najjar","year":"2024","journal-title":"Cells"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.12.004","article-title":"Interleukin-1 receptor-associated kinase-1 (Irak-1) functionally associates with Pkcepsilon and Vasp in the regulation of macrophage migration","volume":"47","author":"Gan","year":"2010","journal-title":"Mol Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1021\/bi500031e","article-title":"Isomerase-catalyzed binding of interleukin-1 receptor-associated kinase 1 to the Evh1 domain of vasodilator-stimulated phosphoprotein","volume":"53","author":"Greenwood","year":"2014","journal-title":"Biochemistry"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.238030","article-title":"Protein phosphatase 2a and neutral sphingomyelinase 2 regulate Irak-1 protein ubiquitination and degradation in response to interleukin-1beta","volume":"286","author":"Dobierzewska","year":"2011","journal-title":"J Biol Chem"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M106103200","article-title":"Protein phosphatase 2a interacts with and directly dephosphorylates Rela","volume":"276","author":"Yang","year":"2001","journal-title":"J Biol Chem"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-3-71","article-title":"Mechanism of Pp2a-mediated Ikk beta dephosphorylation: A systems biological approach","volume":"3","author":"Witt","year":"2009","journal-title":"BMC Syst Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/srep10063","article-title":"Basal protein phosphatase 2a activity restrains cytokine expression: Role for Mapks and Tristetraprolin","volume":"5","author":"Rahman","year":"2015","journal-title":"Sci Rep"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.20.7158-7167.2002","article-title":"Interleukin-1 (Il-1) receptor-associated kinase-dependent Il-1-induced signaling complexes phosphorylate Tak1 and Tab2 at the plasma membrane and activate Tak1 in the cytosol","volume":"22","author":"Jiang","year":"2002","journal-title":"Mol Cell Biol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12964-021-00722-1","article-title":"Protein phosphatases in Tlr signaling","volume":"19","author":"Seumen","year":"2021","journal-title":"Cell Commun Signal"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20170097","article-title":"The mechanism of activation of Irak1 and Irak4 by interleukin-1 and toll-like receptor agonists","volume":"474","author":"Vollmer","year":"2017","journal-title":"Biochem J"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1604","article-title":"Phosphatase Shp-1 promotes Tlr- and Rig-I-activated production of type I interferon by inhibiting the kinase Irak1","volume":"9","author":"An","year":"2008","journal-title":"Nat Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000305","article-title":"Leishmania-induced Irak-1 inactivation is mediated by Shp-1 interacting with an evolutionarily conserved Ktim motif","volume":"2","author":"Abu-Dayyeh","year":"2008","journal-title":"PLoS NeglTrop Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1128\/MCB.00722-12","article-title":"Beta-Trcp-mediated Irak1 degradation releases Tak1-Traf6 from the membrane to the cytosol for Tak1-dependent Nf-Kappab activation","volume":"32","author":"Cui","year":"2012","journal-title":"Mol Cell Biol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M103815200","article-title":"Irak1b, a novel alternative splice variant of interleukin-1 receptor-associated kinase (Irak), mediates interleukin-1 signaling and has prolonged stability","volume":"276","author":"Jensen","year":"2001","journal-title":"J Biol Chem"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.12.001","article-title":"A tissue-specific atlas of mouse protein phosphorylation and expression","volume":"143","author":"Huttlin","year":"2010","journal-title":"Cell"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.09.026","article-title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks","volume":"127","author":"Olsen","year":"2006","journal-title":"Cell"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.R113.032862","article-title":"The coming of age of phosphoproteomics--from large data sets to inference of protein functions","volume":"12","author":"Roux","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.2c00358","article-title":"Sequence coverage visualizer: A web application for protein sequence coverage 3d visualization","volume":"22","author":"Shao","year":"2023","journal-title":"J Proteome Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0430-y","article-title":"Trackviewer: A Bioconductor package for interactive and integrative visualization of multi-omics data","volume":"16","author":"Ou","year":"2019","journal-title":"Nat Methods"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M114.047233","article-title":"A phosphoproteomic comparison of B-Rafv600e and Mkk1\/2 inhibitors in melanoma cells","volume":"14","author":"Stuart","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2518","article-title":"Integrated proteomic analysis of post-translational modifications by serial enrichment","volume":"10","author":"Mertins","year":"2013","journal-title":"Nat Methods"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2069","article-title":"Essential role for the prolyl isomerase Pin1 in toll-like receptor signaling and type I interferon-mediated immunity","volume":"12","author":"Tun-Kyi","year":"2011","journal-title":"Nat Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2000475","article-title":"Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis","volume":"3","author":"Olsen","year":"2010","journal-title":"Sci Signal"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.07.007","article-title":"Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle","volume":"31","author":"Daub","year":"2008","journal-title":"Mol Cell"},{"key":"B85","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","article-title":"Proteogenomics connects somatic mutations to signalling in breast cancer","volume":"534","author":"Mertins","year":"2016","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1179","article-title":"Phosphoproteomic analysis of metformin signaling in colorectal cancer cells elucidates mechanism of action and potential therapeutic opportunities","volume":"13","author":"Salovska","year":"2023","journal-title":"Clin Transl Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.07.036","article-title":"Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser\/Thr-based signaling","volume":"8","author":"Sharma","year":"2014","journal-title":"Cell Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2001497","article-title":"Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells","volume":"4","author":"Kettenbach","year":"2011","journal-title":"Sci Signal"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1021\/pr100637q","article-title":"Feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentation","volume":"9","author":"Nagaraj","year":"2010","journal-title":"J Proteome Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.RA118.000882","article-title":"Decreased Nad activates Stat3 and integrin pathways to drive epithelial-mesenchymal transition","volume":"17","author":"Wang","year":"2018","journal-title":"Mol Cell Proteomics"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1021\/pr300630k","article-title":"Toward a comprehensive characterization of a human cancer cell phosphoproteome","volume":"12","author":"Zhou","year":"2013","journal-title":"J Proteome Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M900335-MCP200","article-title":"Quantitative site-specific phosphorylation dynamics of human protein kinases during mitotic progression","volume":"9","author":"Dulla","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0807567","article-title":"Human Langerhans cells selectively activated via toll-like receptor 2 agonists acquire migratory and Cd4+T cell stimulatory capacity","volume":"83","author":"Peiser","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M113.036392","article-title":"Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels","volume":"13","author":"Mertins","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M106014200","article-title":"Inhibition of interleukin-1beta -induced Nf-Kappa B activation by calcium\/calmodulin-dependent protein kinase kinase occurs through Akt activation associated with interleukin-1 receptor-associated kinase phosphorylation and uncoupling of Myd88","volume":"277","author":"Chen","year":"2002","journal-title":"J Biol Chem"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: Update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2010.05.013","article-title":"A polymorphism in the 3'-Utr of interleukin-1 receptor-associated kinase (Irak1), a target gene of Mir-146a, is associated with rheumatoid arthritis susceptibility","volume":"77","author":"Chatzikyriakidou","year":"2010","journal-title":"Joint Bone Spine"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0901181106","article-title":"Identification of Irak1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus","volume":"106","author":"Jacob","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.70344","article-title":"Analysis of Tnfaip3, Irak1, and Tlr4 gene polymorphisms in patients with rheumatoid arthritis","volume":"14","author":"Tang","year":"2026","journal-title":"Immun Inflammation Dis"},{"key":"B101","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.molimm.2017.03.018","article-title":"Interleukin-1 receptor associated kinase 1 is a potential therapeutic target of anti-inflammatory therapy for systemic lupus erythematosus","volume":"87","author":"Li","year":"2017","journal-title":"Mol Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102181","article-title":"Tlr2 signaling depletes Irak1 and inhibits induction of type I Ifn by Tlr7\/9","volume":"188","author":"Liu","year":"2012","journal-title":"J Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.it.2013.10.005","article-title":"A20 in inflammation and autoimmunity","volume":"35","author":"Catrysse","year":"2014","journal-title":"Trends Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2011.01089.x","article-title":"Micrornas, new effectors and regulators of Nf-Kappab","volume":"246","author":"Boldin","year":"2012","journal-title":"Immunol Rev"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0112-2","article-title":"Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes","volume":"32","author":"Hosseini","year":"2018","journal-title":"Leukemia"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2013.09.008","article-title":"Differential Irak signaling in hematologic Malignancies","volume":"41","author":"Rhyasen","year":"2013","journal-title":"Exp Hematol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ccr.2013.05.006","article-title":"Targeting Irak1 as a therapeutic approach for myelodysplastic syndrome","volume":"24","author":"Rhyasen","year":"2013","journal-title":"Cancer Cell"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4150","article-title":"Targeting Irak1 in T-cell acute lymphoblastic leukemia","volume":"6","author":"Dussiau","year":"2015","journal-title":"Oncotarget"},{"key":"B109","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1182\/blood.2022018718","article-title":"Paralog-specific signaling by Irak1\/4 maintains Myd88-independent functions in Mds\/Aml","volume":"142","author":"Bennett","year":"2023","journal-title":"Blood"},{"key":"B110","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/MOH.0000000000000693","article-title":"Irak1 and Irak4 as emerging therapeutic targets in hematologic Malignancies","volume":"29","author":"Bennett","year":"2022","journal-title":"Curr Opin Hematol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26058","article-title":"Inhibition of interleukin-1 receptor-associated kinase 1 (Irak1) as a therapeutic strategy","volume":"9","author":"Singer","year":"2018","journal-title":"Oncotarget"},{"key":"B112","doi-asserted-by":"publisher","first-page":"8746","DOI":"10.1038\/ncomms9746","article-title":"Irak1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel","volume":"6","author":"Wee","year":"2015","journal-title":"Nat Commun"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1172\/JCI75661","article-title":"Targeting an Ikbke cytokine network impairs triple-negative breast cancer growth","volume":"124","author":"Barbie","year":"2014","journal-title":"J Clin Invest"},{"key":"B114","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003944","article-title":"Irak1 promotes gastric cancer progression by activating the Pi3k\/Akt\/Mtor pathway and inducing the M2 polarization of tumor-associated macrophages","volume":"139","author":"Huang","year":"2026","journal-title":"Chin Med J (Engl)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/ags3.70232","article-title":"Mir-146a-5p suppresses M1 polarization of tumor-associated macrophages via IRAK1\/NF-kappaB signaling in colorectal polyps","volume":"10","author":"Song","year":"2026","journal-title":"Ann Gastroenterol Surg"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2012.00005","article-title":"K63-linked ubiquitination in kinase activation and cancer","volume":"2","author":"Wang","year":"2012","journal-title":"Front Oncol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.02098-07","article-title":"Lys63-linked polyubiquitination of Irak-1 is required for interleukin-1 receptor- and toll-like receptor-mediated Nf-Kappab activation","volume":"28","author":"Conze","year":"2008","journal-title":"Mol Cell Biol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"001858","DOI":"10.1099\/jgv.0.001858","article-title":"IRAK1 inhibition blocks the HIV-1 RNA mediated pro-inflammatory cytokine response from microglia","volume":"104","author":"Campbell","year":"2023","journal-title":"J Gen Virol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01064-7","article-title":"Modulation of Irak enzymes as a therapeutic strategy against Sars-Cov-2 induced cytokine storm","volume":"23","author":"Mahmoud","year":"2023","journal-title":"Clin Exp Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000525292","article-title":"Pacritinib inhibition of Irak1 blocks aberrant Tlr8 signalling by Sars-Cov-2 and Hiv-1-derived Rna","volume":"15","author":"Campbell","year":"2023","journal-title":"J Innate Immun"},{"key":"B123","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11033-025-10473-8","article-title":"Unraveling the role of Irak1 in autoimmune rheumatic diseases: Beyond genetic associations","volume":"52","author":"Sener","year":"2025","journal-title":"Mol Biol Rep"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.104977","article-title":"Bap1 represses sequential activation of Iraks and Nf-Kappab signaling in pancreatic cancer","volume":"21","author":"Zhao","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.3390\/molecules29102226","article-title":"Recent advances in IRAK1: Pharmacological and therapeutic aspects","volume":"29","author":"Kim","year":"2024","journal-title":"Molecules"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.1c00244","article-title":"Targeting irak1 for degradation with protacs","volume":"12","author":"Kargbo","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5818","article-title":"Pacritinib vs best available therapy, including ruxolitinib, in patients with myelofibrosis: A randomized clinical trial","volume":"4","author":"Mascarenhas","year":"2018","journal-title":"JAMA Oncol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.0c00378","article-title":"Discovery of a selective, covalent Irak1 inhibitor with antiproliferative activity in Myd88 mutated B-cell lymphoma","volume":"11","author":"Hatcher","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/nature09671","article-title":"Oncogenically active Myd88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.1c03081","article-title":"1,4-Naphthoquinone is a potent inhibitor of Irak1 kinases and the production of inflammatory cytokines in Thp-1 differentiated macrophages","volume":"6","author":"Mahmoud","year":"2021","journal-title":"ACS Omega"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1021\/tx9902082","article-title":"Role of quinones in toxicology","volume":"13","author":"Bolton","year":"2000","journal-title":"Chem Res Toxicol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"14958","DOI":"10.3390\/ijms232314958","article-title":"Inhibition of IRAK1 is an effective therapy for autoimmune hypophysitis in mice","volume":"23","author":"Huang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/srep42995","article-title":"Thymoquinone: An Irak1 inhibitor with in vivo and in vitro anti-inflammatory activities","volume":"7","author":"Hossen","year":"2017","journal-title":"Sci Rep"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.06.013","article-title":"Mangiferin ameliorates colitis by inhibiting Irak1 phosphorylation in Nf-Kappab and Mapk pathways","volume":"740","author":"Jeong","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/904142","article-title":"The dietary flavonoid kaempferol mediates anti-inflammatory responses via the Src, Syk, Irak1, and Irak4 molecular targets","volume":"2015","author":"Kim","year":"2015","journal-title":"Mediators Inflammation"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/ni.f.209","article-title":"Micrornas: New regulators of immune cell development and function","volume":"9","author":"Baltimore","year":"2008","journal-title":"Nat Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109537200","article-title":"Negative regulation of toll-like receptor-mediated signaling by Tollip","volume":"277","author":"Zhang","year":"2002","journal-title":"J Biol Chem"},{"key":"B138","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.it.2008.10.001","article-title":"The Pellino family: Irak E3 ligases with emerging roles in innate immune signalling","volume":"30","author":"Moynagh","year":"2009","journal-title":"Trends Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-5793(03)00697-5","article-title":"Characterization of pellino2, a substrate of irak1 and irak4","volume":"547","author":"Strelow","year":"2003","journal-title":"FEBS Lett"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(02)00449-1","article-title":"Socs-1 participates in negative regulation of Lps responses","volume":"17","author":"Nakagawa","year":"2002","journal-title":"Immunity"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00103","article-title":"Discovery of highly potent and selective Irak1 degraders to probe scaffolding functions of Irak1 in Abc Dlbcl","volume":"64","author":"Fu","year":"2021","journal-title":"J Med Chem"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.011857","article-title":"A highly selective inhibitor of interleukin-1 receptor-associated kinases 1\/4 (Irak-1\/4) delineates the distinct signaling roles of Irak-1\/4 and the Tak1 kinase","volume":"295","author":"Scarneo","year":"2020","journal-title":"J Biol Chem"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c02988","article-title":"Discovery of novel, potent, and selective Irak1 inhibitors as potential therapeutics for hepatocellular carcinoma","volume":"69","author":"Min","year":"2026","journal-title":"J Med Chem"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.09.008","article-title":"Emerging interleukin-1 receptor-associated kinase 4 (Irak4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer","volume":"14","author":"Feng","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B145","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1182\/blood-2024-206096","article-title":"R289, a dual Irak 1\/4 inhibitor, in patients with relapsed\/refractory (R\/R) lower-risk myelodysplastic syndrome (Lr-Mds): Initial results from a phase 1b study","volume":"144","author":"Garcia-Manero","year":"2024","journal-title":"Blood"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.5c00147","article-title":"Irak1\/4\/Pan-Flt3 kinase inhibitors with reduced Herg block as treatments for acute myeloid leukemia","volume":"16","author":"Hoyt","year":"2025","journal-title":"ACS Med Chem Lett"},{"key":"B147","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41375-025-02816-y","article-title":"Targeting Il-1\/Irak1\/4 signaling in acute myeloid leukemia stem cells following treatment and relapse","volume":"40","author":"Ho","year":"2026","journal-title":"Leukemia"},{"key":"B148","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1182\/blood-2023-189899","article-title":"Kme-0584, a highly potent Irak1\/Irak4\/Panflt3 inhibitor, is a promising clinical candidate for hypomethylating agent plus venetoclax resistant Aml\/Mds patients","volume":"142","author":"Rosenbaum","year":"2023","journal-title":"Blood"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/mas.21636","article-title":"Widening the bottleneck of phosphoproteomics: Evolving strategies for phosphopeptide enrichment","volume":"40","author":"Low","year":"2021","journal-title":"Mass Spectrom Rev"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M112.017863","article-title":"Quantitative phosphoproteomic analysis reveals a role for serine and threonine kinases in the cytoskeletal reorganization in early T cell receptor activation in human primary T cells","volume":"11","author":"Ruperez","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M400077-MCP200","article-title":"Phosphotyrosine proteomic study of interferon alpha signaling pathway using a combination of immunoprecipitation and immobilized metal affinity chromatography","volume":"4","author":"Zheng","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1039\/c5mb00024f","article-title":"Why phosphoproteomics is still a challenge","volume":"11","author":"Solari","year":"2015","journal-title":"Mol Biosyst"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.O113.034181","article-title":"Status of large-scale analysis of post-translational modifications by mass spectrometry","volume":"12","author":"Olsen","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.098137","article-title":"Irak1 and Irak4 promote phosphorylation, ubiquitination, and degradation of Myd88 adaptor-like (Mal)","volume":"285","author":"Dunne","year":"2010","journal-title":"J Biol Chem"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.116052","article-title":"Emerging precision drug delivery systems for controlled activation of the cgas-sting pathway in cancer, infection, and autoimmune disorders","volume":"170","author":"Pavani","year":"2026","journal-title":"Int Immunopharmacol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2026.109704","article-title":"Benzimidazole derived non-cdn sting agonists: Mechanisms, sar evolution, and therapeutic potential - a comprehensive review","volume":"174","author":"Pavani","year":"2026","journal-title":"Bioorg Chem"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1111\/febs.13943","article-title":"Neighboring phosphoser-pro motifs in the Undefined domain of Irak1 impart bivalent advantage for Pin1 binding","volume":"283","author":"Rogals","year":"2016","journal-title":"FEBS J"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1172\/JCI75821","article-title":"Inhibition of Irak1\/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies","volume":"125","author":"Li","year":"2015","journal-title":"J Clin Invest"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/nature01182","article-title":"Essential role for Tirap in activation of the signalling cascade shared by Tlr2 and Tlr4","volume":"420","author":"Yamamoto","year":"2002","journal-title":"Nature"},{"key":"B160","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/35092578","article-title":"Mal (Myd88-adapter-like) is required for Toll-like receptor-4 signal transduction","volume":"413","author":"Fitzgerald","year":"2001","journal-title":"Nature"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/ni0901-835","article-title":"Tirap: An adapter molecule in the Toll signaling pathway","volume":"2","author":"Horng","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in Nf-kappab signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210413","article-title":"Ubiquitin-mediated activation of tak1 and ikk","volume":"26","author":"Adhikari","year":"2007","journal-title":"Oncogene"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2015.02.020","article-title":"Quantifying ubiquitin signaling","volume":"58","author":"Ordureau","year":"2015","journal-title":"Mol Cell"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/nature02794","article-title":"De-ubiquitination and ubiquitin ligase domains of A20 downregulate Nf-kappab signalling","volume":"430","author":"Wertz","year":"2004","journal-title":"Nature"},{"key":"B166","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The Jak-Stat pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1002\/art.39245","article-title":"A20-binding inhibitor of Nf-kappab activation 1 is a physiologic inhibitor of Nf-kappab: A molecular switch for inflammation and autoimmunity","volume":"67","author":"G'Sell","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/ni968","article-title":"Sigirr, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling","volume":"4","author":"Wald","year":"2003","journal-title":"Nat Immunol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s0092-8674(02)00827-9","article-title":"Irak-M is a negative regulator of Toll-like receptor signaling","volume":"110","author":"Kobayashi","year":"2002","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1937314\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:21:54Z","timestamp":1788412914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1937314\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":170,"alternative-id":["10.3389\/fimmu.2026.1937314"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1937314","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1937314"}}